Skip to main content
Erschienen in: Pediatric Radiology 12/2016

15.08.2016 | Original Article

Early characteristic radiographic changes in mucolipidosis II

verfasst von: Lillian M. Lai, Ralph S. Lachman

Erschienen in: Pediatric Radiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Although mucolipidosis type II has similar metabolic abnormalities to those found in all the mucopolysaccharidoses and mucolipidoses, there are distinctive diagnostic radiographic changes of mucolipidosis II in the perinatal/newborn/infant period.

Objective

To describe the early characteristic radiographic changes of mucolipidosis II and to document when these changes manifest and resolve.

Materials and methods

We retrospectively reviewed radiographs and clinical records of 19 cases of mucolipidosis II from the International Skeletal Dysplasia Registry (1971–present; fetal age to 2½ years). A radiologist with special expertise in skeletal dysplasias evaluated the radiographs.

Results

The most common abnormalities were increased vertebral body height (80%, nonspecific), talocalcaneal stippling (86%), periosteal cloaking (74%) and vertebral body rounding (50%). Unreported findings included sacrococcygeal sclerosis (54%) and vertebral body sclerosis (13%). Rickets and hyperparathyroidism-like (pseudohyperparathyroidism) changes (rarely reported) were found in 33% of cases. These changes invariably started in the newborn period and resolved by 1 year of age. The conversion from these early infantile radiographic features to dysostosis multiplex changes occurred in 41% of cases, and within the first year after birth.

Conclusion

Several findings strongly suggest the diagnosis of mucolipidosis II, including cloaking in combination with one or more of the following radiographic criteria: talocalcaneal stippling, sacrococcygeal or generalized vertebral body sclerosis, vertebral body rounding, or rickets/hyperparathyroidism-like changes in the perinatal/newborn/infancy period. These findings are not found in the other two forms of mucolipidosis nor in any of the mucopolysaccharidoses.
Literatur
1.
Zurück zum Zitat Kollmann K, Pestka JM, Kühn SC et al (2013) Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med 5:1871–1886CrossRefPubMedPubMedCentral Kollmann K, Pestka JM, Kühn SC et al (2013) Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med 5:1871–1886CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat David-Vizcarra G, Briody J, Ault J et al (2010) The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 46:316–322CrossRefPubMedPubMedCentral David-Vizcarra G, Briody J, Ault J et al (2010) The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 46:316–322CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Lachman RS, Burton BK, Clarke LA et al (2014) Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. Skeletal Radiol 43:359–369CrossRefPubMedPubMedCentral Lachman RS, Burton BK, Clarke LA et al (2014) Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. Skeletal Radiol 43:359–369CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Cathey SS, Leroy JG, Wood T et al (2010) Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 47:38–48CrossRefPubMed Cathey SS, Leroy JG, Wood T et al (2010) Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 47:38–48CrossRefPubMed
5.
Zurück zum Zitat Leroy JG, Cathey S, Friez MJ (2012) Mucolipidosis II. In: Ragon RA, Adam MP, Ardinger HH et al (eds) GeneReviews. University of Washington, Seattle, pp 1–24 Leroy JG, Cathey S, Friez MJ (2012) Mucolipidosis II. In: Ragon RA, Adam MP, Ardinger HH et al (eds) GeneReviews. University of Washington, Seattle, pp 1–24
6.
Zurück zum Zitat Leroy JG, Demars RI (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157:804–806CrossRefPubMed Leroy JG, Demars RI (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157:804–806CrossRefPubMed
7.
Zurück zum Zitat Leroy JG, Spranger JW (1970) I-cell disease. N Engl J Med 283:598–599PubMed Leroy JG, Spranger JW (1970) I-cell disease. N Engl J Med 283:598–599PubMed
8.
Zurück zum Zitat Maroteaux P, Lamy M (1966) Hurler’s pseudo-polydystrophy. Presse Med 74:2889–2892PubMed Maroteaux P, Lamy M (1966) Hurler’s pseudo-polydystrophy. Presse Med 74:2889–2892PubMed
9.
Zurück zum Zitat Landing B, Silverman F, Craig J et al (1964) Familial neurovisceral lipidosis: an analysis of eight cases of a syndrome previously reported as ‘Hurler-variant’, ‘Pseudo-Hurler disease’, and ‘Tay-Sachs disease with visceral involvement’. Am J Dis Child 108:503–522CrossRefPubMed Landing B, Silverman F, Craig J et al (1964) Familial neurovisceral lipidosis: an analysis of eight cases of a syndrome previously reported as ‘Hurler-variant’, ‘Pseudo-Hurler disease’, and ‘Tay-Sachs disease with visceral involvement’. Am J Dis Child 108:503–522CrossRefPubMed
10.
Zurück zum Zitat Leroy JG, Sillence D, Wood T et al (2014) A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain. Eur J Hum Genet 22:594–601CrossRefPubMed Leroy JG, Sillence D, Wood T et al (2014) A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain. Eur J Hum Genet 22:594–601CrossRefPubMed
11.
Zurück zum Zitat Taber P, Gyepes MT, Philippart M et al (1973) Roentgenographic manifestations of Leroy’s I-cell disease. Am J Roentgenol Radium Ther Nucl Med 118:213–221CrossRefPubMed Taber P, Gyepes MT, Philippart M et al (1973) Roentgenographic manifestations of Leroy’s I-cell disease. Am J Roentgenol Radium Ther Nucl Med 118:213–221CrossRefPubMed
12.
Zurück zum Zitat Lin MH-C, Pitukcheewanont P (2012) Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab 25:191–195PubMed Lin MH-C, Pitukcheewanont P (2012) Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab 25:191–195PubMed
13.
Zurück zum Zitat Pazzaglia UE, Beluffi G, Danesino C et al (1989) Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment. Report of two cases. Pediatr Radiol 20:80–84CrossRefPubMed Pazzaglia UE, Beluffi G, Danesino C et al (1989) Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment. Report of two cases. Pediatr Radiol 20:80–84CrossRefPubMed
14.
Zurück zum Zitat Pazzaglia UE, Beluffi G, Campbell JB et al (1989) Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr Radiol 19:406–413CrossRefPubMed Pazzaglia UE, Beluffi G, Campbell JB et al (1989) Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr Radiol 19:406–413CrossRefPubMed
15.
Zurück zum Zitat Alegra T, Cury G, Todeschini LA et al (2013) Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically? J Pediatr Endocrinol Metab 26:1011–1013CrossRefPubMed Alegra T, Cury G, Todeschini LA et al (2013) Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically? J Pediatr Endocrinol Metab 26:1011–1013CrossRefPubMed
16.
Zurück zum Zitat Sathasivam A, Garibaldi L, Murphy R et al (2006) Transient neonatal hyperparathyroidism: a presenting feature of mucolipidosis type II. J Pediatr Endocrinol Metab 19:859–862CrossRefPubMed Sathasivam A, Garibaldi L, Murphy R et al (2006) Transient neonatal hyperparathyroidism: a presenting feature of mucolipidosis type II. J Pediatr Endocrinol Metab 19:859–862CrossRefPubMed
17.
Zurück zum Zitat Saul RA, Proud V, Taylor HA et al (2005) Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 135:328–332CrossRefPubMed Saul RA, Proud V, Taylor HA et al (2005) Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 135:328–332CrossRefPubMed
18.
Zurück zum Zitat Lachman R, Taybi H (2006) Taybi and Lachman’s radiology of syndromes, metabolic disorders, and skeletal dysplasias, 5th edn. Mosby, Philadelphia Lachman R, Taybi H (2006) Taybi and Lachman’s radiology of syndromes, metabolic disorders, and skeletal dysplasias, 5th edn. Mosby, Philadelphia
Metadaten
Titel
Early characteristic radiographic changes in mucolipidosis II
verfasst von
Lillian M. Lai
Ralph S. Lachman
Publikationsdatum
15.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Radiology / Ausgabe 12/2016
Print ISSN: 0301-0449
Elektronische ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3673-0

Weitere Artikel der Ausgabe 12/2016

Pediatric Radiology 12/2016 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.